Decline depth
-25.2%
From rolling 252-day high of $7.18, 111d ago.
Past the 20% Watch threshold.
-25.2%
from rolling 252-day high of $7.18 set 2026-01-23 · 111d ago
Current
$5.37
Decline depth
-25.2%
Decline σ
8.5σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
ANNX qualifies for the Red List on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
8.5σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.29% per day).
Past the ≥8σ Red List threshold — an extreme move.
The structural read
What price action says about ANNX.
ANNX qualifies for the Red List on decline depth — down -25.2% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown.
Cross-confirmation: decline sigma also reads 8.5σ over 20 bars.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 1 (red), monthly 1 (red).
Earnings on file: 2026-05-07. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $1.67
67.2% of range
52W high $7.18
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
92
Red List
43
Amber
47
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to ANNX
Watch
INGN
Inogen, Inc
Watch Recovering
SVRA
Savara, Inc.
Watch
OMER
Omeros Corporation
Watch
HRMY
Harmony Biosciences Holdings, I
Watch
ABEO
Abeona Therapeutics Inc.
Amber List
ADUS
Addus HomeCare Corporation
Questions about ANNX
What people ask.
Why is ANNX on Broken Stocks?
ANNX qualifies for the Red List on decline depth. It is down -25.2% from its rolling 252-day high of $7.18, set on 2026-01-23 — 111d ago.
Is ANNX a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. ANNX is down -25.2% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is ANNX a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is ANNX trading inside its 52-week range?
At $5.37, ANNX sits 67.2% of the way from its 52-week low ($1.67) to its 52-week high ($7.18). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has ANNX been declining?
The current 25.2% decline accrued over 111d, which annualizes to roughly -82.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does ANNX compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 92 Red, 43 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — ANNX's decline is shallower than the sector median.
Does ANNX's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-07) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.